# Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss

> clinical trial · VERIFIED · 2026-08-27

Status: RECRUITING · Sponsor: Skylark Bio Inc. · Condition: GJB2-mediated Hearing Loss

- Company: Skylark Bio Inc.
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT07627971

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.